Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

NEXT STORY
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
PREV STORY
Global Rapid Medical Diagnostic Kits Markets, 2020-2027: Lipid Profile, Blood Glucose, Toxicology, Infectious Disease, Coagulation, Cardiometabolic , Fecal Occult Blood, & Pregnancy and Fertility
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019

author_avatar
NASDAQ Market News

Inventiva to present at the Jefferies 2019 London Healthcare Conference

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials

FIT Biotech Oy                                                                                                                                                                                                           Press release 27.8.2018 at 08.30 AM EET FIT Biotech ...

author_avatar
NASDAQ Market News